Interacting Drugs |
Ezetimibe and simvastatin vs Rifamycin Derivatives |
Security Level |
 |
Mechanism |
Rifamycin Derivatives: May decrease the serum concentration of HMG-CoA Reductase Inhibitors. Rifamycin Derivatives may increase the serum concentration of HMG-CoA Reductase Inhibitors. |
Management |
Consider therapy modification |
Ezetimibe and simvastatin vs Rifamycin Derivatives
Post Review about Ezetimibe and simvastatin vs Rifamycin Derivatives Click here to cancel reply.
Other Interactions of Ezetimibe and simvastatin
Other Interactions of Rifamycin Derivatives
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.